Sabadell Asabys, a private equity firm, led a €17m Series B round in DeepUll, a medical diagnostics company, with participation from Innvierte, Kurma Partners, Alta Life sciences, UI Investissement and Axis Participaciones Empresariales. “We are delighted to bring Asabys as a new investor to DeepUll. Asabys’ belief in health technologies and their expertise investing in life sciences innovation, add great value to the company, supporting our growth and helping us reach relevant milestones for the ultimate benefit of patients," Jordi Carrera, DeepUll Co-Founder and CEO.